Promoting Quality in Drug Manufacturing

Pharmaceutical Technology, Pharmaceutical Technology-09-02-2004, Volume 28, Issue 9

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.